Sebastian Wehle
Director/Miembro de la Junta en TIGENIX NV .
Cargos activos de Sebastian Wehle
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TIGENIX NV | Director/Miembro de la Junta | 15/06/2018 | - |
Historial de carrera de Sebastian Wehle
Antiguos cargos conocidos de Sebastian Wehle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Formación de Sebastian Wehle.
| University of Kiel | Doctorate Degree |
Estadísticas
Internacional
| Bélgica | 2 |
| Japón | 2 |
| Alemania | 2 |
Operativa
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
- Bolsa de valores
- Insiders
- Sebastian Wehle
- Experiencia
